Health
Proteogenomics can help determine effective treatment for head and neck squamous cell carcinoma – News-Medical.Net
Proteogenomic analysis may offer new insight into matching cancer patients with an effective therapy for their particular cancer.
Proteogenomic analysis may offer new insight into matching cancer patients with an effective therapy for their particular cancer. A new study identifies three molecular subtypes in head and neck squamous cell carcinoma (HNSCC) that could be used to better determine appropriate treatment. The research led by Baylor College of Medicine, Johns Hopkins University and the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) is published in the journal Cancer Cell.
Researchers…
-
Noosa News17 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business20 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business17 hours agoDicker Data rides the AI trend to double digit growth
-
Business20 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy